أعرض في EDS

Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group

التفاصيل البيبلوغرافية
العنوان:	Ribosome biogenesis‐based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group
المؤلفون:	Nour‐El‐Houda Mourksi, Cécile Dalban, Amélie Colombe‐Vermorel, Laetitia Odeyer, Valentin Simioni, Jean‐Sébastien Frenel, Michel Fabbro, Fernando Bazan, Sophie Abadie‐Lacourtoisie, Elodie Coquan, Séverine Martinez, Gwenaelle Garin, Séverine Tabone‐Eglinger, Isabelle Treilleux, Sylvie Chabaud, David Pérol, Isabelle Ray‐Coquard, Pierre‐Etienne Heudel, Jean‐Jacques Diaz, Virginie Marcel
المصدر:	Molecular Oncology. 17:27-36
بيانات النشر:	Wiley, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Cancer Research, Oncology, Genetics, Molecular Medicine, General Medicine
تدمد:	1878-0261 1574-7891
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=doi_________::929dd2cc532a0879cba0fe2fca6520b0Test https://doi.org/10.1002/1878-0261.13340Test
حقوق:	OPEN
رقم الانضمام:	edsair.doi...........929dd2cc532a0879cba0fe2fca6520b0
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	18780261 15747891